Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.70 PHP
Change Today -0.09 / -5.03%
Volume 3.0K
As of 2:24 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

euro-med laboratories phil (EURO) Snapshot

Open
$1.70
Previous Close
$1.79
Day High
$1.70
Day Low
$1.70
52 Week High
03/31/15 - $2.89
52 Week Low
12/16/14 - $1.06
Market Cap
7.0B
Average Volume 10 Days
67.8K
EPS TTM
$0.05
Shares Outstanding
4.1B
EX-Date
06/16/14
P/E TM
35.3x
Dividend
$0.05
Dividend Yield
2.94%
Current Stock Chart for EURO-MED LABORATORIES PHIL (EURO)

Related News

No related news articles were found.

euro-med laboratories phil (EURO) Related Businessweek News

No Related Businessweek News Found

euro-med laboratories phil (EURO) Details

Euro-Med Laboratories Phil., Inc. manufactures and sells large and small volume parenterals and other solutions in the Philippines. The company operates through Manufacturing, Service, and Food Service segments. It offers parenteral products in glass and plastic containers. The company also manufactures sterile water for injection; intravenous fluids and special fluids; tablets and syrups/suspensions; antiseptic, feminine wash, cleansing, gargle, and vaginal solutions; products for nebulization and injection; intravenous sets; and other solutions, such as ophthalmic, inhalation, irrigation, and dialysis. In addition, it is involved in the operation of a dialysis center; distribution of venipuncture sets, IV administration sets, and IV equipment, as well as Limulus Amebocyte Lysate test kits; manufacture of purified and distilled drinking water; and toll manufacturing of pharmaceuticals. Further, the company is engaged in the operation of restaurants and bakeries, as well as provides food services, catering, food production, and related services. Euro-Med Laboratories Phil., Inc. exports its pharmaceutical products internationally. The company was incorporated in 1988 and is based in Manila, the Philippines. Euro-Med Laboratories Phil., Inc. operates as a subsidiary of U.S Automotive, Inc.

1,419 Employees
Last Reported Date: 04/16/15
Founded in 1988

euro-med laboratories phil (EURO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

euro-med laboratories phil (EURO) Key Developments

Euro-Med Laboratories Philippines Inc. expected to report Q1 2015 results on May 22, 2015. This event was calculated by Capital IQ (Created on May 17, 2015).

Euro-Med Laboratories Philippines Inc. expected to report Q1 2015 results on May 22, 2015. This event was calculated by Capital IQ (Created on May 17, 2015).

Euro-Med Laboratories Philippines Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Year 2015

Euro-Med Laboratories Philippines Inc. reported unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of PHP 641,736,780 against PHP 723,096,181 a year ago. Operating loss was PHP 38,523,711 against PHP 34,708,809 a year ago. Income before income tax was PHP 34,636,364 against PHP 32,767,359 a year ago. Net income was PHP 24,245,455 or PHP 0.006 per basic and diluted share against PHP 22,937,151 or PHP 0.006 per basic and diluted share a year ago. Net cash provided by operating activities was PHP 137,713,994 against net cash used in operating activities of PHP 122,208,874 a year ago. Acquisitions of property, plant and equipment was PHP 16,834,032 against PHP 14,698,001 a year ago. Acquisition of intangible assets was PHP 45,063 against PHP 45,063 a year ago. Total debt was PHP 3,712,460,979 against PHP 3,801,365,783 a year ago. The company's net sales decreased by 11% from PHP 723.1 million. The decrease in sales was attributed to the decrease in local sales which decreased by 7.2% from PHP 651.7 million in the first quarter of 2014 to PHP 604.4 million in the first quarter of 2015. Export sales decreased by 47.8% from PHP 71.4 million for the first quarter of 2014 to PHP 37.3 million for the first quarter of 2015. For the year 2015, the company expects to increase its sales in 2015 by about 7% primarily due to the expected increase in Export sales and increase in sales of CafeFrance Corp. and Hemotek Renal Center Inc. The parent company is continuously expanding its present product lines to include specially products for inhalation, opthalmic, irrigation and other health care purposes. Likewise, it expects to open new export markets in other countries and increases the number of products being exported. The subsidiaries are continuously opening-up new branches throughout the country. The expected net income for 2015 is about PHP 214 million, which is about 4% to 5% of sales.

Euro-Med Laboratories Philippines Inc. Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

Euro-Med Laboratories Philippines Inc. reported audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported revenues of PHP 4,703,582,459 against PHP 4,566,888,124 a year ago. Operating income was PHP 461,772,364 against PHP 423,144,446 a year ago. Income before tax was PHP 300,013,752 against PHP 272,420,598 a year ago. Net income was PHP 207,189,826 against PHP 188,721,199 a year ago. Basic and diluted earnings per share attributable to equity holders of the parent company were PHP 0.05 against PHP 0.05 a year ago. Net cash provided by operating activities was PHP 334,292,671 against PHP 231,725,644 a year ago. Acquisitions of property, plant and equipment was PHP 268,645,433 against PHP 378,230,388 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EURO:PM $1.70 PHP -0.09

EURO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EURO.
View Industry Companies
 

Industry Analysis

EURO

Industry Average

Valuation EURO Industry Range
Price/Earnings 35.0x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 34.8x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EURO-MED LABORATORIES PHIL, please visit www.euromedlab.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.